Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Total Current Liabilities (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Total Current Liabilities of $5.93 million for Q2 2026, down 50.9% from $12.08 million a year earlier and down 3.0% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Total Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Reviva Pharmaceuticals Holdings' Total Current Liabilities came in at $7.28 million, down 50.2% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 40.4% (FY2020 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Total Current Liabilities was $14.6 million in FY2024 (-15.0%), $17.18 million in FY2023 (+72.4%) and $9.96 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Total Current Liabilities since Q2 2022.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last seven quarters, with an average decline of 30.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2022, with growth of 555.2%; the weakest was Q2 2026, with a decline of 50.9%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $6.12 million (Q1 2026), $7.28 million (Q4 2025) and $9.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - 5.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.93 Mn
Mar 31, 2026 6.12 Mn
Dec 31, 2025 7.28 Mn
Sep 30, 2025 9.74 Mn
Jun 30, 2025 12.08 Mn
Mar 31, 2025 11.51 Mn
Dec 31, 2024 14.60 Mn
Sep 30, 2024 17.53 Mn
Jun 30, 2024 13.94 Mn
Mar 31, 2024 14.49 Mn
Dec 31, 2023 17.18 Mn
Sep 30, 2023 17.32 Mn
Jun 30, 2023 12.64 Mn
Mar 31, 2023 10.73 Mn
Dec 31, 2022 9.96 Mn
Sep 30, 2022 6.38 Mn
Jun 30, 2022 4.48 Mn
Mar 31, 2022 3.62 Mn
Dec 31, 2021 2.34 Mn
Sep 30, 2021 973,700.00
API Access

Reviva Pharmaceuticals Holdings Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RVPH&period=max&api_key=YOUR_API_KEY